Yaron Werber
Stock Analyst at TD Cowen
(2.16)
# 2,819
Out of 5,179 analysts
44
Total ratings
38.71%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Maintains: Hold | $116 → $94 | $85.68 | +9.71% | 6 | Mar 11, 2026 | |
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $16.80 | +25.00% | 3 | Jan 22, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $14.48 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $19.38 | +287.00% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $41.53 | +22.80% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $691.40 | +65.75% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $72.15 | +37.21% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $2.00 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.19 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $283.03 | +18.01% | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $25.50 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $81.13 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $23.87 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $216.95 | -29.48% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $8.67 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.85 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.05 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.96 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $30.30 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.79 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $25.82 | +47.17% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $26.52 | - | 1 | Oct 26, 2021 |
BioNTech SE
Mar 11, 2026
Maintains: Hold
Price Target: $116 → $94
Current: $85.68
Upside: +9.71%
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $16.80
Upside: +25.00%
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $14.48
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $19.38
Upside: +287.00%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $41.53
Upside: +22.80%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $691.40
Upside: +65.75%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $72.15
Upside: +37.21%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.00
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.19
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $283.03
Upside: +18.01%
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $25.50
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $81.13
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $23.87
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $216.95
Upside: -29.48%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $8.67
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $32.85
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.05
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.96
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $30.30
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $7.79
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $25.82
Upside: +47.17%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $26.52
Upside: -